Crestchem Hits New 52-Week Low at Rs. 110 Amid Market Gains

Crestchem, a microcap player in the specialty chemicals industry, has reached a new 52-week low, hitting Rs. 110 today, November 17, 2025. This decline marks a significant downturn for the stock, which has underperformed its sector by 2.59% and has seen a consecutive fall over the past three days, resulting in a total drop of 4.8% during this period. The stock also touched an intraday low of Rs. 110, reflecting an 8.03% decrease.
Crestchem's performance over the past year has been notably challenging, with a staggering decline of 53.48%, contrasting sharply with the Sensex's positive return of 9.50%. The company's financial metrics indicate weak long-term fundamental strength, with a modest 19.73% CAGR growth in operating profits over the last five years. Additionally, the company's ability to service its debt appears compromised, as evidenced by a poor EBIT to interest ratio of 1.75.

As Crestchem continues to trade below its moving averages across various time frames, the market remains focused on the underlying trends affecting its performance.